Eureka Genomics Corp.

Next-gen sequencing start-up Eureka Genomics says its novel algorithms and data structures are especially effective for the analysis of large sets of short genomic subsequences. The company can analyze sequencing data for non-host genetic material, such as bacteria or viruses. It can also design ultraspecific signature sequences that can be used to detect pathogens or ganisms of interest. In addition to its sequencing service business, Eureka intends to generate novel diagnostics, therapeutic targets and possible vaccines based on microorganisms associated with disease.